Impact of Yondeli™ (trabectedin, ET-743) in the natural history of patients (pts) with pretreated advanced soft tissue sarcomas (PASTS): Long term follow-up results Meeting Abstract
| Authors: | Lecesne, A.; Demetri, G.; Misset, J. L.; Blay, J.; Judson, I.; Yovine, A.; van Oosterom, A.; Radford, J.; Verweij, J.; Maki, R.; Brain, E.; Herait, P.; Izquierdo, M. A.; Gomez, J.; Nieto, A.; Saro, J.; Jimeno, J. |
| Abstract Title: | Impact of Yondeli™ (trabectedin, ET-743) in the natural history of patients (pts) with pretreated advanced soft tissue sarcomas (PASTS): Long term follow-up results |
| Meeting Title: | 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| Journal Title: | Clinical Cancer Research |
| Volume: | 9 |
| Issue: | 16 Pt. 2 |
| Meeting Dates: | 2003 Nov 17-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2003-12-01 |
| Start Page: | 6076s |
| Language: | English |
| ACCESSION: | WOS:000187467300032 |
| PROVIDER: | wos |
| PUBMED: | 14712828 |
| Notes: | Meeting Abstract: #A31 -- Poster Session A -- Source: Wos |
